Daruwala Paul 4
4 · Cidara Therapeutics, Inc. · Filed Apr 5, 2021
Insider Transaction Report
Form 4
Daruwala Paul
Chief Medical Officer
Transactions
- Sale
Common Stock
2021-04-01$2.66/sh−593$1,577→ 50,531 total - Sale
Common Stock
2021-01-05$2.06/sh−2,868$5,908→ 49,724 total - Award
Common Stock
2021-03-31+1,400→ 51,124 total
Footnotes (3)
- [F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs on 1/1/21. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- [F2]The reporting person was previously granted a performance restricted stock unit (PRSU) to vest upon the achievement of a certain milestone event that occurred on 3/31/21.
- [F3]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of PRSUs on 03/31/21. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.